Skip to content

PLAY2CONTROL Study

Active Video Games and Their Effect on Weight Loss and HgbA1c in Patients With Obesity and Type 2 Diabetes Mellitus

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07556679
Enrollment
30
Registered
2026-04-29
Start date
2026-10-01
Completion date
2027-10-01
Last updated
2026-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity & Overweight, Type 2 Diabetes

Keywords

Pediatrics

Brief summary

The purpose of this study is to assess the impact of active video gaming participation in otherwise sedentary patients with obesity and Type 2 diabetes mellitus. The study will assess changes in sedentary time, activity level and changes in weight and Hemoglobin A1c, as well as other complications related to obesity that is monitored in clinic.

Interventions

BEHAVIORALNex Playground Activity Program

Participants are provided with a Nex Playground gaming console and asked to use it regularly at home for no less than 20 minutes at a time, unless otherwise doing another physical activity or sport for this timeframe.

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

* Patients followed at the University of Miami Pediatric Endocrinology Clinic * Must have a diagnosis of Obesity (BMI \>= 95th percentile) and Type 2 Diabetes Mellitus (Hemoglobin A1c \> 6.5%) * Children and teenagers, 5-18 years old * Young adults 19-21 years old

Exclusion criteria

* Patients who have conditions preventing physical activity (such as physical limitations) * Patients without Televisions at home * Pregnant females * Patients in juvenile detention or prison * Adults unable to consent

Design outcomes

Primary

MeasureTime frameDescription
Percent Weight ChangeBaseline to 12 monthsPercent change in body weight (percentage points) from baseline, measured using clinic calibrated scales during routine visits
Change in HbA1cBaseline to 12 monthsAbsolute change in HbA1c (percentage points) from baseline, measured through standard laboratory blood tests performed during routine clinic visits

Secondary

MeasureTime frameDescription
Change in Lipids LevelsBaseline to 12 monthsChange in lipids levels (milligrams per deciliter) from baseline, measured through fasting lipid panels obtained during routine clinic blood work
Change in Liver EnzymesBaseline to 12 monthsChange in liver enzymes (units per liter) measured through standard liver function tests obtained during routine clinic blood work
Change in Oral Diabetes Medication DoseBaseline to 12 monthsChange in doses of oral antihyperglycemic medications (milligrams), as recorded in the medical record and summarized using the prescribed daily or weekly doses.
Change in Insulin DoseBaseline to 12 monthsChange in insulin dose (units), as recorded in the medical record and summarized as the total prescribed daily insulin units
Change in Sedentary TimeBaseline to 12 monthsAbsolute change in daily sedentary time (hours), assessed via a clinic-administered sedentary behavior questionnaire. Sedentary time will be reported as total hours per day.

Countries

United States

Contacts

CONTACTJessica Landau, D.O.
jessica.landau@jhsmiami.org305-243-2920
PRINCIPAL_INVESTIGATORPatricia Gomez, M.D.

University of Miami

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 28, 2026